Cargando…
Simvastatin–Ezetimibe enhances growth factor expression and attenuates neuron loss in the hippocampus in a model of intracerebral hemorrhage
Intracerebral hemorrhage (ICH) is a common and severe neurological disorder associated with high morbidity and mortality rates. Despite extensive research into its pathology, there are no clinically approved neuroprotective treatments for ICH. Increasing evidence has revealed that inflammatory respo...
Autores principales: | Wang, Kuo‐Wei, Liang, Cheng‐Loong, Yeh, Lee‐Ren, Liu, Kuo‐Ying, Chen, Chao‐Chi, Chen, Jui‐Sheng, Chen, Han‐Jung, Wang, Hao‐Kuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451876/ https://www.ncbi.nlm.nih.gov/pubmed/33278834 http://dx.doi.org/10.1111/fcp.12635 |
Ejemplares similares
-
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
por: Rotella, Carlo M, et al.
Publicado: (2010) -
Anti-inflammatory effects of Simvastatin in patients with acute intracerebral hemorrhage in an intensive care unit
por: Zhou, Xiurong, et al.
Publicado: (2017) -
Simvastatin Combined with Antioxidant Attenuates the Cerebral Vascular Endothelial Inflammatory Response in a Rat Traumatic Brain Injury
por: Wang, Kuo-Wei, et al.
Publicado: (2014) -
Simvastatin Upregulates Lipoxin A4 and Accelerates Neuroinflammation Resolution After Intracerebral Hemorrhage
por: Zhang, Jianbo, et al.
Publicado: (2022) -
Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia
por: Visseren, F. L. J.
Publicado: (2011)